Preclinical research evidence Animal Experiments Obese mouse model: After subcutaneous injection of AOD 9604 (250 g/kg) daily for 8 weeks, the body weight of obese mice decreased by 12%, the subcutaneous fat mass decreased by 25%, and the weight of epididymal adipose tissue decreased significantly
The October 1, 2025 release applies to services through March 31, 2026
Dont wait to feel your bestcontact us today for a consultation at our MedHealth 360 wellness clinic at 19500 Sandridge Way, Suite 350, Leesburg, VA 20176
J Clin Microbiol 53:28772888
By decoupling weight loss from appetite suppression and stimulants, it offers a cleaner, more sustainable approach to metabolic health
Traditional Formulations of Copper Peptides Often Face These Challenges: Low Skin Penetration: The hydrophilic nature of copper peptide ghk-cu limits absorption across the skin barrier